RxDoctor Payments Data

Sameer Berry, MD

Gastroenterology · New York, NYNPI 1740636059

Payments from drug & device makers

$4,389in general payments, 2019–2025

Across 18 payments — averaging $243.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$4K
  • Medtronic$333
  • Olympus America Inc.$149
  • Bristol Myers Squibb$85
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$83
  • Lilly USA, LLC$71
  • plus $16 from 1 others

What the payments were for

  • Consulting fees$3,65383%
  • Travel & lodging$812%
  • Food & beverage$65615%

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,389 in reported general payments places this provider in the 60th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York

Medicare billing

Part B allowed, 2024
$16,102
Medicare patients
66
Services billed
106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →